摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

trans-2-(m-nitrophenyl)cyclopropanecarboxylic acid

中文名称
——
中文别名
——
英文名称
trans-2-(m-nitrophenyl)cyclopropanecarboxylic acid
英文别名
trans 2-(3-nitrophenyl)cyclopropylcarboxylic acid;(+/-)-trans-2-(3-nitro-phenyl)-cyclopropanecarboxylic acid;(+/-)-trans-2-(3-Nitro-phenyl)-cyclopropancarbonsaeure;(1S,2S)-2-(3-nitrophenyl)cyclopropane-1-carboxylic acid
trans-2-(m-nitrophenyl)cyclopropanecarboxylic acid化学式
CAS
——
化学式
C10H9NO4
mdl
——
分子量
207.186
InChiKey
MZCREXORTQFYPP-BDAKNGLRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.78
  • 重原子数:
    15.0
  • 可旋转键数:
    3.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    80.44
  • 氢给体数:
    1.0
  • 氢受体数:
    3.0

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    trans-2-(m-nitrophenyl)cyclopropanecarboxylic acid盐酸二苯基膦叠氮化物三乙胺 作用下, 以 甲醇 为溶剂, 反应 48.0h, 生成 trans-2-(3-Nitrophenyl)cyclopropanamine
    参考文献:
    名称:
    探索A3腺苷受体结合位点的远端区域:在空间上受约束的N6-(2-苯乙基)腺苷衍生物作为有效的配体。
    摘要:
    我们合成了N(6)-(1S,2R)-(2-苯基-1-环丙基)腺苷的苯环取代类似物,其与人A(3)AR的结合力强,Ki值为0.63 nM。测量了这些结构变化对人和大鼠腺苷受体的亲和力以及对hA(3)AR的内在功效的影响。3-硝基苯基类似物色谱分离成纯的非对映异构体,在A(3)AR结合中表现出10倍的立体选择性,有利于1S,2R异构体。分子模型在苯基部分周围的假定的A(3)AR结合位点中定义了疏水区(Phe168)。杂芳族基团(3-噻吩基)可以取代苯基部分,并保留A(3)AR结合的高亲和力。包括其他相关的N(6)取代腺苷衍生物进行比较。尽管N(6)-(2-苯基-1-环丙基)衍生物是完全的A(3)AR激动剂,但其他几种衍生物的功效也大大降低。N(6)-环丙基腺苷是一种A(3)AR拮抗剂,在环丙基部分的2位添加一个或两个苯环可恢复功效。N(6)-(2,2-二苯基乙基)腺苷是一种A(3)AR拮抗剂,
    DOI:
    10.1016/j.bmc.2004.02.037
  • 作为产物:
    描述:
    3-硝基苯乙烯copper(l) chloride 、 potassium hydroxide 作用下, 以 乙醇氯仿 为溶剂, 反应 4.0h, 生成 trans-2-(m-nitrophenyl)cyclopropanecarboxylic acid
    参考文献:
    名称:
    Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blasts
    摘要:
    The pure enantiomers of the N-(2-, 3-, and 4-(2-aminocyclopropyl)phenyl)benzamides hydrochlorides 11a-j were prepared and tested against LSD1 and MAO enzymes. The evaluation of the regioisomers 11a-j highlighted a net increase of the anti-LSD1 potency by shifting the benzamide moiety from ortho to meta and mainly to para position of tranylcypromine phenyl ring, independently from their trans or cis stereochemistry. In particular, the para-substituted 11a,b (trans) and 11g,h (cis) compounds displayed LSD1 and MAO-A inhibition at low nanomolar levels, while were less potent against MAO-B. The meta analogs 11c,d (trans) and 11i,j (cis) were in general less potent, but more efficient against MAO-A than against LSD1. In cellular assays, all the para and meta enantiomers were able to inhibit LSD1 by inducing Gfi-1b and ITGAM gene expression, with 11b,c and 11g-i giving the highest effects. Moreover, 11b and 11g,h strongly inhibited the clonogenic potential of murine promyelocytic blasts. (C) 2015 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2015.02.060
点击查看最新优质反应信息

文献信息

  • Conjugative Transmission in Cyclopropane Systems
    作者:Edward N. Trachtenberg、George Odian
    DOI:10.1021/ja01548a051
    日期:1958.8
  • Korp, James D.; Bernal, Ivan; Fuchs,, Richard, Canadian Journal of Chemistry, 1983, vol. 61, p. 50 - 56
    作者:Korp, James D.、Bernal, Ivan、Fuchs,, Richard
    DOI:——
    日期:——
  • Pure enantiomers of benzoylamino-tranylcypromine: LSD1 inhibition, gene modulation in human leukemia cells and effects on clonogenic potential of murine promyelocytic blasts
    作者:Sergio Valente、Veronica Rodriguez、Ciro Mercurio、Paola Vianello、Bruna Saponara、Roberto Cirilli、Giuseppe Ciossani、Donatella Labella、Biagina Marrocco、Daria Monaldi、Giovanni Ruoppolo、Mats Tilset、Oronza A. Botrugno、Paola Dessanti、Saverio Minucci、Andrea Mattevi、Mario Varasi、Antonello Mai
    DOI:10.1016/j.ejmech.2015.02.060
    日期:2015.4
    The pure enantiomers of the N-(2-, 3-, and 4-(2-aminocyclopropyl)phenyl)benzamides hydrochlorides 11a-j were prepared and tested against LSD1 and MAO enzymes. The evaluation of the regioisomers 11a-j highlighted a net increase of the anti-LSD1 potency by shifting the benzamide moiety from ortho to meta and mainly to para position of tranylcypromine phenyl ring, independently from their trans or cis stereochemistry. In particular, the para-substituted 11a,b (trans) and 11g,h (cis) compounds displayed LSD1 and MAO-A inhibition at low nanomolar levels, while were less potent against MAO-B. The meta analogs 11c,d (trans) and 11i,j (cis) were in general less potent, but more efficient against MAO-A than against LSD1. In cellular assays, all the para and meta enantiomers were able to inhibit LSD1 by inducing Gfi-1b and ITGAM gene expression, with 11b,c and 11g-i giving the highest effects. Moreover, 11b and 11g,h strongly inhibited the clonogenic potential of murine promyelocytic blasts. (C) 2015 Elsevier Masson SAS. All rights reserved.
  • Exploring distal regions of the A3 adenosine receptor binding site: sterically constrained N6-(2-phenylethyl)adenosine derivatives as potent ligands
    作者:Susanna Tchilibon、Soo-Kyung Kim、Zhan-Guo Gao、Brian A Harris、Joshua B Blaustein、Ariel S Gross、Heng T Duong、Neli Melman、Kenneth A Jacobson
    DOI:10.1016/j.bmc.2004.02.037
    日期:2004.5
    putative A(3)AR binding site around the phenyl moiety. A heteroaromatic group (3-thienyl) could substitute for the phenyl moiety with retention of high affinity of A(3)AR binding. Other related N(6)-substituted adenosine derivatives were included for comparison. Although the N(6)-(2-phenyl-1-cyclopropyl) derivatives were full A(3)AR agonists, several other derivatives had greatly reduced efficacy. N(6)
    我们合成了N(6)-(1S,2R)-(2-苯基-1-环丙基)腺苷的苯环取代类似物,其与人A(3)AR的结合力强,Ki值为0.63 nM。测量了这些结构变化对人和大鼠腺苷受体的亲和力以及对hA(3)AR的内在功效的影响。3-硝基苯基类似物色谱分离成纯的非对映异构体,在A(3)AR结合中表现出10倍的立体选择性,有利于1S,2R异构体。分子模型在苯基部分周围的假定的A(3)AR结合位点中定义了疏水区(Phe168)。杂芳族基团(3-噻吩基)可以取代苯基部分,并保留A(3)AR结合的高亲和力。包括其他相关的N(6)取代腺苷衍生物进行比较。尽管N(6)-(2-苯基-1-环丙基)衍生物是完全的A(3)AR激动剂,但其他几种衍生物的功效也大大降低。N(6)-环丙基腺苷是一种A(3)AR拮抗剂,在环丙基部分的2位添加一个或两个苯环可恢复功效。N(6)-(2,2-二苯基乙基)腺苷是一种A(3)AR拮抗剂,
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐